Patents by Inventor Philippe Bournat

Philippe Bournat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8334254
    Abstract: The invention concerns the use of a recombinant nucleotide sequence containing a cDNA coding for a lactoferrin, in particular human lactoferrin, or the derived proteins, and elements enabling a plant cell to produce lactoferrin or the derived proteins, coded by the cDNA, in particular a transcription promoter and terminator identified by the plant cell transcription machinery, to transform plant cells in order to obtain, from these cells, or plants obtained therefrom, lactoferrin or derived proteins.
    Type: Grant
    Filed: April 8, 2008
    Date of Patent: December 18, 2012
    Assignee: EDULIS
    Inventors: Dominique Legrand, Valerie Salmon, Genevieve Spik, Veronique Gruber, Philippe Bournat, Bertrand Merot
  • Publication number: 20110092411
    Abstract: The invention concerns the use of a recombinant nucleotide sequence containing a DNAc coding for a lactoferrin, in particular human lactoferrin, or the derived proteins, and elements enabling a plant cell to produce lactoferrin or the derived proteins, coded by said DNAc, in particular a transcription promoter and terminator identified by the plant cell transcription machinery, to transform plant cells in order to obtain, from these cells, or plants obtained therefrom, lactoferrin or derived proteins.
    Type: Application
    Filed: April 8, 2008
    Publication date: April 21, 2011
    Inventors: Dominique Legrand, Valerie Salmon, Genevieve Spik, Veronique Gruber, Philippe Bournat, Bertrand Merot
  • Patent number: 7354902
    Abstract: The invention concerns the use of a recombinant nucleotide sequence containing a cDNA coding for a lactoferrin, in particular human lactoferrin, or the derived proteins, and elements enabling a plant cell to produce lactoferrin or the derived proteins, coded by said cDNA, in particular a transcription promoter and terminator identified by the plant cell transcription machinery, to transform plant cells in order to obtain, from these cells, or plants obtained therefrom, lactoferrin or derived proteins.
    Type: Grant
    Filed: May 27, 2003
    Date of Patent: April 8, 2008
    Assignee: Meristem Therapeutics S.A.
    Inventors: Dominique Legrand, Valerie Salmon, Genevieve Spik, Veronique Gruber, Philippe Bournat, Bertrand Merot
  • Publication number: 20030229925
    Abstract: The invention concerns the use of a recombinant nucleotide sequence containing a cDNA coding for a lactoferrin, in particular human lactoferrin, or the derived proteins, and elements enabling a plant cell or produce lactoferrin or the derived proteins, coded by said cDNA, in particular a transcription promoter and terminator identified by the plant cell transcription machinery, to transform plant cells in order to obtain, from these cells, or plants obtained therefrom, lactoferrin or derived proteins.
    Type: Application
    Filed: May 27, 2003
    Publication date: December 11, 2003
    Applicant: Meristem Therapeutics S.A.
    Inventors: Dominique Legrand, Valerie Salmon, Genevieve Spik, Veronique Gruber, Philippe Bournat, Bertrand Merot
  • Patent number: 6617431
    Abstract: The invention concerns the use of a recombinant nucleotide sequence containing a cDNA coding for one or several mammalian collagen chains or derived proteins and elements enabling a plant cell to produce the collagen chains(s) or derived proteins, coded by said cDNA, particularly a transcription promoter and terminator identified by the transcription machinery of the plant cells, for transforming the plant cells so as to obtain from these cells, or plants obtained from them, the collagen chain(s) or derived proteins. The invention also concerns the resulting proteins and transformed plant material as well as their uses.
    Type: Grant
    Filed: August 17, 1999
    Date of Patent: September 9, 2003
    Assignee: Meristem Therapeutics S.A.
    Inventors: Veronique Gruber, Jean-Yves Exposito, Florence Ruggiero, Jeanne Comte, Robert Garrone, Bertrand Merot, Philippe Bournat
  • Patent number: 6569831
    Abstract: The invention concerns the use of a recombinant nucleotide sequence containing a cDNA coding for a lactoferrin, in particular human lactoferrin, or the derived proteins, and elements enabling a plant cell to produce lactoferrin or the derived proteins, coded by the cDNA, in particular a transcription promoter and terminator identified by the plant cell transcription machinery, to transform plant cells in order to obtain, from these cells, or plants obtained therefrom, lactoferrin or derived proteins.
    Type: Grant
    Filed: March 21, 2000
    Date of Patent: May 27, 2003
    Assignee: Meristem Therapeutics S.A.
    Inventors: Dominique Legrand, Valerie Salmon, Genevieve Spik, Veronique Gruber, Philippe Bournat, Bertrand Merot
  • Publication number: 20030096973
    Abstract: The invention concerns the use of a recombinant nucleotide sequence containing a cDNA coding for one or several mammal collagen chains or derived proteins and elements enabling a plant cell to produce the collagen chain(s) or derived proteins, coded by said cDNA, particularly a transcription promoter and terminator identified by the transcription machinery of the plant cells, for transforming the plant cells so as to obtain from these cells, or plants obtained from them, the collagen chain(s) or derived proteins.
    Type: Application
    Filed: August 9, 2002
    Publication date: May 22, 2003
    Applicant: Meristem Therapeutics S.A.
    Inventors: Veronique Gruber, Jean-Yves Exposito, Florence Ruggiero, Jeanne Comte, Robert Garrone, Bertrand Merot, Philippe Bournat